Viatris Announces Agreement to Monetize its Equity Stake in Biocon Biologics Limited
Provided By PR Newswire
Last update: Dec 6, 2025
Viatris to Receive $400 Million in Cash and $415 Million in Equity Shares of Biocon Limited
Transaction Accelerates the Expiration of Biosimilars Non-Compete Restrictions
Read more at prnewswire.com
